Background Adverse drug reactions (ADRs) are a leading cause of preventable hospitalization, yet the dominant pharmacovigilance paradigm remains reactive. Machine learning (ML) offers a data-driven alternative, but the evidence base has not been formally meta-analyzed under clinically realistic inclusion criteria and a...
G. Cappello, C. Oster, T. Schmidt et al.· Frontiers in Pharmacology· 0 citations
BACKGROUND
The role of balloon guide catheters (BGC) in endovascular thrombectomy for acute ischemic stroke remains controversial, with conflicting evidence regarding clinical outcomes. We evaluated the impact of BGC use on periprocedural metrics and early neurological improvement (ENI).
METHODS
In this retrospective...
Natalie van Landeghem, Katharina Kölker, Jordi Kühne Escolà et al.· Neuroradiology· 0 citations
Re-irradiation (re-RT) has gained popularity in the treatment of recurrent or progressive glioblastoma (rGBM) after first-line treatment. However, uncertainties regarding optimal treatment dose, fraction size and target volume definition remain. In this multicenter analysis of the Western German Cancer Center (WT...
N. Pepper, M. Guberina, C. Poettgen et al.· Neuro-Oncology Advances· 0 citations
We use cookies to run the site and, with your consent, for analytics and to show ads.
See our Cookie Policy.